---
title: "FOXO Settles J.H. Darbie Claims With 400 Series D Preferred Shares and $175,000 Cash"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287407091.md"
description: "FOXO Technologies has settled claims with J.H. Darbie by issuing 400 Series D preferred shares and agreeing to pay $175,000 in installments from May to December 2026. If FOXO defaults, J.H. Darbie can convert unpaid amounts into Class A Common Stock at a specified rate. The agreement aims to resolve prior obligations under various agreements."
datetime: "2026-05-22T21:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287407091.md)
  - [en](https://longbridge.com/en/news/287407091.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287407091.md)
generator: "portal-rs"
---

# FOXO Settles J.H. Darbie Claims With 400 Series D Preferred Shares and $175,000 Cash

FOXO Technologies entered into a Settlement Agreement and Release with J.H. Darbie to resolve all obligations under prior finder, advisory, and private placement agreements. FOXO will issue 400 shares of Series D cumulative convertible redeemable preferred stock and pay $175,000 in seven monthly $25,000 installments from May through December 2026. If FOXO defaults on payments, J.H. Darbie may convert the unpaid balance into Class A Common Stock at 90% of the 20-day VWAP, capped at 4.99% beneficial ownership. J.H. Darbie also received piggyback registration rights for conversion shares.

**Agreement details:**

-   **Agreement type**: Settlement Agreement and Release resolving prior finder, advisory, and private placement obligations
-   **Counterparty**: J.H. Darbie & Co.
-   **Signed / Effective**: May 15 2026 / same
-   **Duration / Termination**: Through Dec 31 2026
-   **Reason**: Resolve outstanding obligations to J.H. Darbie

Original SEC Filing: FOXO TECHNOLOGIES INC. \[ FOXO \] - 8-K - May. 22, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [FOXOW.US](https://longbridge.com/en/quote/FOXOW.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [FOXO.US](https://longbridge.com/en/quote/FOXO.US.md)

## Related News & Research

- [BIONATION 2026 to Bring Canada’s Life Sciences Sector Together in Ottawa](https://longbridge.com/en/news/299236957.md)
- [FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS | FOXO Stock News](https://longbridge.com/en/news/291808819.md)
- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight](https://longbridge.com/en/news/299655817.md)
- [FOXO unit Vector BioSource agrees to buy four Grifols blood collection centers in US asset deal](https://longbridge.com/en/news/294208635.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**